Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers

Gastroenterology

Volumn 142, Issue 2, 2012, Pages 219-232

  White, Bryan D ^a   Chien, Andy J ^b   Dawson, David W ^c  

^a UNIVERSITY OF WASHINGTON BOTHELL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colorectal Carcinoma; Hepatocellular Carcinoma; Pancreatic Ductal Ddenocarcinoma; catenin; Wnt

Indexed keywords

ANTINEOPLASTIC AGENT; APC PROTEIN; BETA CATENIN; CWP 231A; CWP 232291; IWP 2; PRI 724; UNCLASSIFIED DRUG; WNT PROTEIN; XAV 939;

CANCER GENETICS; COLORECTAL CARCINOMA; DRUG TARGETING; GENE FUNCTION; GENE MUTATION; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; ONCOGENE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

EID: 84856191525     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.12.001     Document Type: Review

References (137)

1. A.J. Chien, W.H. Conrad, R.T. Moon A Wnt survival guide: from flies to human disease J Invest Dermatol 129 2009 1614 1627
2. A.J. Chien, R.T. Moon WNTS and WNT receptors as therapeutic tools and targets in human disease processes Front Biosci 12 2007 448 457
3. R.T. Moon, A.D. Kohn, G.V. De Ferrari WNT and beta-catenin signalling: diseases and therapies Nat Rev Genet 5 2004 691 701
4. B.T. MacDonald, K. Tamai, X. He Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev Cell 17 2009 9 26
5. S. Angers, R.T. Moon Proximal events in Wnt signal transduction Nat Rev Mol Cell Biol 10 2009 468 477
6. R.T. Moon Wnt/beta-catenin pathway Sci STKE 2005 2005 cm1
7. D. Kimelman, W. Xu Beta-catenin destruction complex: insights and questions from a structural perspective Oncogene 25 2006 7482 7491
8. F. Rijsewijk, M. Schuermann, E. Wagenaar The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless Cell 50 1987 649 657
9. C. Yost, M. Torres, J.R. Miller The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3 Genes Dev 10 1996 1443 1454
10. S.L. McDonald, A. Silver The opposing roles of Wnt-5a in cancer Br J Cancer 101 2009 209 214
11. M. Nishita, M. Enomoto, K. Yamagata Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells Trends Cell Biol 20 2010 346 354
12. M.B. Major, N.D. Camp, J.D. Berndt Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling Science 316 2007 1043 1046
13. M.B. Major, B.S. Roberts, J.D. Berndt New regulators of Wnt/beta-catenin signaling revealed by integrative molecular screening Sci Signal 1 2008 ra12
14. M. Shitashige, S. Hirohashi, T. Yamada Wnt signaling inside the nucleus Cancer Sci 99 2008 631 637
15. S. Brabletz, O. Schmalhofer, T. Brabletz Gastrointestinal stem cells in development and cancer J Pathol 217 2009 307 317
16. A. Gregorieff, H. Clevers Wnt signaling in the intestinal epithelium: from endoderm to cancer Genes Dev 19 2005 877 890
17. F. Radtke, H. Clevers Self-renewal and cancer of the gut: two sides of a coin Science 307 2005 1904 1909
18. R.H. Giles, J.H. van Es, H. Clevers Caught up in a Wnt storm: Wnt signaling in cancer Biochim Biophys Acta 1653 2003 1 24
19. R. Fodde, T. Brabletz Wnt/beta-catenin signaling in cancer stemness and malignant behavior Curr Opin Cell Biol 19 2007 150 158
20. A. Mrtensson, A. Oberg, A. Jung Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer Oncol Rep 17 2007 447 452
21. W. Wanitsuwan Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers World J Gastroenterol 14 2008 6052
22. A. Elzagheid, A. Buhmeida, E. Korkeila Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma World J Gastroenterol 14 2008 3866 3871
23. A.B. Sparks, P.J. Morin, B. Vogelstein Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer Cancer Res 58 1998 1130 1134
24. W.S. Samowitz, M.D. Powers, L.N. Spirio Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas Cancer Res 59 1999 1442 1444
25. V. Johnson, E. Volikos, S.E. Halford Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome Gut 54 2005 264 267
26. A. Scholer-Dahirel, M.R. Schlabach, A. Loo Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/β-catenin signaling Proc Natl Acad Sci U S A 108 2011 17135 17140
27. L. Mologni, H. Dekhil, M. Ceccon Colorectal tumors are effectively eradicated by combined inhibition of β-catenin, KRAS, and the oncogenic transcription factor ITF2 Cancer Res 70 2010 7253 7263
28. C.A. Hanson, J.R. Miller Non-traditional roles for the adenomatous polyposis coli (APC) tumor suppressor protein Gene 361 2005 1 12
29. R. Fodde, J. Kuipers, C. Rosenberg Mutations in the APC tumour suppressor gene cause chromosomal instability Nat Cell Biol 3 2001 433 438
30. K.B. Kaplan, A.A. Burds, J.R. Swedlow A role for the Adenomatous Polyposis Coli protein in chromosome segregation Nat Cell Biol 3 2001 429 432
31. C. Albuquerque, C. Breukel, R. van der Luijt The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade Hum Mol Genet 11 2002 1549 1560
32. C. Gaspar, R. Fodde APC dosage effects in tumorigenesis and stem cell differentiation Int J Dev Biol 48 2004 377 386
33. C. Gaspar, P. Franken, L. Molenaar A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis PLoS Genet 5 2009 e1000547
34. M. Buchert, D. Athineos, H.E. Abud Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo PLoS Genet 6 2010 e1000816
35. M.M. Taketo, W. Edelmann Mouse models of colon cancer Gastroenterology 136 2009 780 798
36. K.P. Janssen, P. Alberici, H. Fsihi APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression Gastroenterology 131 2006 1096 1109
37. T. Tanaka, H. Kohno, R. Suzuki Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms Int J Cancer 118 2006 25 34
38. L. Vermeulen, F. De Sousa E Melo, M. van der Heijden Wnt activity defines colon cancer stem cells and is regulated by the microenvironment Nat Cell Biol 12 2010 468 476
39. T. Brabletz, A. Jung, K. Hermann Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front Pathol Res Pract 194 1998 701 704
40. W. de Lau, N. Barker, T.Y. Low Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling Nature 476 2011 293 297
41. K.S. Carmon, X. Gong, Q. Lin R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling Proc Natl Acad Sci U S A 108 2011 11452 11457
42. A. Glinka, C. Dolde, N. Kirsch LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling EMBO Rep 12 2011 1055 1061
43. O. Kazanskaya, A. Glinka, I. del Barco Barrantes R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis Dev Cell 7 2004 525 534
44. K.A. Kim, M. Kakitani, J. Zhao Mitogenic influence of human R-spondin1 on the intestinal epithelium Science 309 2005 1256 1259
45. A. Merlos-Suarez, F.M. Barriga, P. Jung The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse Cell Stem Cell 8 2011 511 524
46. H. Takahashi, H. Ishii, N. Nishida Significance of Lgr5(+ve) cancer stem cells in the colon and rectum Ann Surg Oncol 18 2011 1166 1174
47. Y. Yamamoto, M. Sakamoto, G. Fujii Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations Hepatology 37 2003 528 533
48. C. Kwon, P. Cheng, I.N. King Notch post-translationally regulates β-catenin protein in stem and progenitor cells Nat Cell Biol 13 2011 1 9
49. S. Arimura, A. Matsunaga, T. Kitamura Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling Gastroenterology 137 2009 629 638
50. G.R. van den Brink, Sa Bleuming, J.C.H. Hardwick Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation Nat Genet 36 2004 277 282
51. L. Zender, A. Villanueva, V. Tovar Cancer gene discovery in hepatocellular carcinoma J Hepatol 52 2010 921 929
52. Y. Miyoshi, K. Iwao, Y. Nagasawa Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3 Cancer Res 58 1998 2524 2527
53. A. de La Coste, B. Romagnolo, P. Billuart Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas Proc Natl Acad Sci U S A 95 1998 8847 8851
54. J. Cui, X. Zhou, Y. Liu Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes J Gastroenterol Hepatol 18 2003 280 287
55. P. Polakis The oncogenic activation of beta-catenin Curr Opin Genet Dev 9 1999 15 21
56. K. Taniguchi, L.R. Roberts, I.N. Aderca Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas Oncogene 21 2002 4863 4871
57. Y.-D. Kim, C.-H. Park, H.-S. Kim Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma J Gastroenterol Hepatol 23 2008 110 118
58. S. Satoh, Y. Daigo, Y. Furukawa AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 Nat Genet 24 2000 245 250
59. J. Zucman-Rossi, S. Benhamouche, C. Godard Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas Oncogene 26 2007 774 780
60. Y. Hoshida, S.M.B. Nijman, M. Kobayashi Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res 69 2009 7385 7392
61. S.S. Thorgeirsson, J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 2002 339 346
62. T. Fukutomi, Y. Zhou, S. Kawai Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression Hepatology 41 2005 1096 1105
63. Y.-B. Deng, G. Nagae, Y. Midorikawa Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma Cancer Sci 101 2010 1501 1510
64. A. Hsieh, H.-S. Kim, S.-O. Lim Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling Cancer Lett 300 2011 162 172
65. P.L. Puig, P. Legoix, O. Bluteau Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis Gastroenterology 120 2001 1763 1773
66. K.N. Nejak-Bowen, S.P.S. Monga Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad Semin Cancer Biol 21 2011 44 58
67. D.F. Calvisi, V.M. Factor, R. Loi Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade Cancer Res 61 2001 2085 2091
68. D.F. Calvisi, V.M. Factor, S. Ladu Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice Gastroenterology 126 2004 1374 1386
69. D.F. Calvisi, Ea Conner, S. Ladu Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer J Hepatol 42 2005 842 849
70. A. Cadoret, C. Ovejero, S. Saadi-Kheddouci Hepatomegaly in transgenic mice expressing an oncogenic form of β-catenin Cancer 61 2001 3245 3249
71. N. Harada, H. Miyoshi, N. Murai Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of β-catenin Cancer 62 2002 1971 1977
72. X. Tan, U. Apte, A. Micsenyi Epidermal growth factor receptor: a novel target of the wnt/β-catenin pathway in liver Gastroenterology 129 2005 285 302
73. S. Colnot, T. Decaens, M. Niwa-Kawakita Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas Proc Natl Acad Sci U S A 101 2004 17216 17221
74. R. Fodde The multiple functions of tumour suppressors: it's all in APC Nat Cell Biol 5 2003 190 192
75. N. Harada Hepatocarcinogenesis in mice with β-catenin and Ha-ras gene mutations Cancer Res 64 2004 48 54
76. H. Miyoshi, A. Deguchi, M. Nakau Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+/- mice Cancer Sci 100 2009 2046 2053
77. K.N. Nejak-Bowen, M.D. Thompson, S. Singh Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin Hepatology 51 2010 1603 1613
78. S. Boyault, D.S. Rickman, A. de Reynis Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52
79. D.Y. Chiang, A. Villanueva, Y. Hoshida Focal gains of VEGFA and molecular classification of hepatocellular carcinoma Cancer Res 68 2008 6779 6788
80. P. Merle, S. de la Monte, M. Kim Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma Gastroenterology 127 2004 1110 1122
81. T. Toyama, H.C. Lee, H. Koga Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration Mol Cancer Res 8 2010 254 265
82. C.L. Stoick-Cooper, G. Weidinger, K.J. Riehle Distinct Wnt signaling pathways have opposing roles in appendage regeneration Development 134 2007 479 489
83. G. Zulehner, M. Mikula, D. Schneller Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence Am J Pathol 176 2010 472 481
84. A.N. Fischer, E. Fuchs, M. Mikula PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression Oncogene 26 2007 3395 3405
85. H. Jian, X. Shen, I. Liu Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells Genes Dev 20 2006 666 674
86. M.P. Ceballos, J.P. Parody, M.D.L. Alvarez Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma? Biochem Pharmacol 82 2011 1682 1691
87. L. Trusolino, A. Bertotti, P.M. Comoglio MET signalling: principles and functions in development, organ regeneration and cancer Nat Rev Mol Cell Biol 11 2010 834 848
88. S.P. Monga, W.M. Mars, P. Pediaditakis Hepatocyte growth factor induces Wnt-independent nuclear translocation of β-catenin after Met-β-catenin dissociation in hepatocytes Cancer Res 62 2002 2064 2071
89. T. Ueki, J. Fujimoto, T. Suzuki Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma Hepatology 25 1997 862 866
90. P. Kaposi-Novak, J.S. Lee, L. Gmez-Quiroz Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype J Clin Invest 116 2006 1582 1595
91. C.M. Wong, S.T. Fan, I.O. Ng Beta-catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance Cancer 92 2001 136 145
92. S. Inagawa, M. Itabashi, S. Adachi Expression and prognostic roles of β-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival Clin Cancer Res 8 2002 450 456
93. L.T. Tien, M. Ito, M. Nakao Expression of β-catenin in hepatocellular carcinoma J Gastroenterol 11 2005 2398 2401
94. J.T. Nhieu, C.A. Renard, Y. Wei Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation Am J Pathol 155 1999 703 710
95. T.L. Mao, J.S. Chu, Y.M. Jeng Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis J Pathol 193 2001 95 101
96. H.C. Hsu, Y.M. Jeng, T.L. Mao Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis Am J Pathol 157 2000 763 770
97. T.Y. Lai, C.C. Su, W.W. Kuo Beta-catenin plays a key role in metastasis of human hepatocellular carcinoma Oncol Rep 26 2011 415 422
98. H. Wege, D. Heim, M. Ltgehetmann Forced activation of β-catenin signaling supports the transformation of hTERT-immortalized human fetal hepatocytes Mol Cancer Res 9 2011 1222 1231
99. W. Wei, M.-S. Chua, S. Grepper Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells Mol Cancer 8 2009 76
100. S. Jones, X. Zhang, D.W. Parsons Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 2008 1801 1806
101. S.M. Hong, J.Y. Park, R.H. Hruban Molecular signatures of pancreatic cancer Arch Pathol Lab Med 135 2011 716 727
102. G. Zeng, M. Germinaro, A. Micsenyi Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma Neoplasia 8 2006 279 289
103. B. Gerdes, A. Ramaswamy, B. Simon Analysis of beta-catenin gene mutations in pancreatic tumors Digestion 60 1999 544 548
104. R.H. Hruban, M. Bishop Pittman, D.S. Klimstra Tumors of the pancreas 2007 ARP Press Washington, DC
105. D.A. Tuveson, S.R. Hingorani Ductal pancreatic cancer in humans and mice Cold Spring Harb Symp Quant Biol 70 2005 65 72
106. I.V. Morris JP, S.C. Wang, M. Hebrok KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma Nat Rev Cancer 10 2010 683 695
107. P.W. Heiser, J. Lau, M.M. Taketo Stabilization of beta-catenin impacts pancreas growth Development 133 2006 2023 2032
108. A. Strom, C. Bonal, R. Ashery-Padan Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas Development 134 2007 2719 2725
109. P.W. Heiser, D.A. Cano, L. Landsman Stabilization of beta-catenin induces pancreas tumor formation Gastroenterology 135 2008 1288 1300
110. J.P. Morris IV, D.A. Cano, S. Sekine Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice J Clin Invest 120 2010 508 520
111. A. Vincent, N. Omura, S.M. Hong Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma Clin Cancer Res 17 2011 4341 4354
112. A.D. Rhim, B.Z. Stanger Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways Prog Mol Biol Transl Sci 97 2010 41 78
113. M. Pasca di Magliano, A.V. Biankin, P.W. Heiser Common activation of canonical Wnt signaling in pancreatic adenocarcinoma PLoS ONE 2 2007 e1155
114. L. Hanlon, J.L. Avila, R.M. Demarest Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma Cancer Res 70 2010 4280 4286
115. D. Romero, M. Iglesias, C.P. Vary Functional blockade of Smad4 leads to a decrease in beta-catenin levels and signaling activity in human pancreatic carcinoma cells Carcinogenesis 29 2008 1070 1076
116. A. Blackford, O.K. Serrano, C.L. Wolfgang SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer Clin Cancer Res 15 2009 4674 4679
117. A.W. Lowe, M. Olsen, Y. Hao Gene expression patterns in pancreatic tumors, cells and tissues PLoS ONE 2 2007 e323
118. D. Cao, A. Maitra, J.A. Saavedra Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways Mod Pathol 18 2005 752 761
119. A.M. Lowy, C. Fenoglio-Preiser, O.J. Kim Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma Ann Surg Oncol 10 2003 284 290
120. F.E. Froeling, T.A. Mirza, R.M. Feakins Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells Am J Pathol 175 2009 636 648
121. L. Wang, D.G. Heidt, C.J. Lee Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization Cancer Cell 15 2009 207 219
122. R. Chetty, S. Serra, S. Salahshor Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis Hum Pathol 37 2006 212 217
123. Y.E. Joo, J.S. Rew, C.S. Park Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma Pancreatology 2 2002 129 137
124. A.J. Karayiannakis, K.N. Syrigos, A. Polychronidis Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis Anticancer Res 21 2001 4127 4134
125. Y.J. Li, Z.M. Wei, Y.X. Meng Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis World J Gastroenterol 11 2005 2117 2123
126. Q. Qiao, M. Ramadani, S. Gansauge Reduced membranous and ectopic cytoplasmic expression of beta -catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer Int J Cancer 95 2001 194 197
127. R. Nawroth, A. van Zante, S. Cervantes Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells PLoS ONE 2 2007 e392
128. J.-P. Lai, A.M. Oseini, C.D. Moser The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation Hepatology 52 2010 1680 1689
129. Y. Zhong, Z. Wang, B. Fu GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1 PLoS ONE 6 2011 e22129
130. A. Koenig, C. Mueller, C. Hasel Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells Cancer Res 66 2006 4662 4671
131. F.E. Froeling, C. Feig, C. Chelala Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression Gastroenterology 141 2011 1486 1497
132. S.M. Huang, Y.M. Mishina, S. Liu Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling Nature 461 2009 614 620
133. B. Chen, M.E. Dodge, W. Tang Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer Nat Chem Biol 5 2009 100 107
134. K.H. Emami, C. Nguyen, H. Ma A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected] Proc Natl Acad Sci U S A 101 2004 12682 12687
135. T. Miki, S.Y. Yasuda, M. Kahn Wnt/beta-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming Stem Cell Rev 7 2011 836 846
136. O.M. Lucero, D.W. Dawson, R.T. Moon A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers Curr Oncol Rep 12 2010 314 318
137. T. Biechele, N. Camp, D. Fass Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma Chem Biol 17 2010 1177 1182